A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study
The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Purpose An optimal target for glucose control in ICU patients remains unclear. This prospective randomized controlled trial compared the effects on ICU mortality of intensive insulin therapy (IIT) with an intermediate glucose control. Methods Adult patients admitted to the 21 participating medico-surgical ICUs were randomized to group 1 (target BG 7.8-10.0 mmol/L) or to group 2 (target BG 4.4-6.1 mmol/L). Results While the required sample size was 1,750 per group, the trial was stopped early due to a high rate of unintended protocol violations. From 1,101 admissions, the outcomes of 542 patients assigned to group 1 and 536 of group 2 were analysed. The groups were well balanced. BG levels averaged in group 1 8.0 mmol/L (IQR 7.1-9.0) (median of all values) and 7.7 mmol/L (IQR 6.7-8.8) (median of morning BG) versus 6.5 mmol/L (IQR 6.0-7.2) and 6.1 mmol/L (IQR 5.5-6.8) for group 2 (p Conclusions In this prematurely stopped and therefore underpowered study, there was a lack of clinical benefit of intensive insulin therapy (target 4.4-6.1 mmol/L), associated with an increased incidence of hypoglycaemia, as compared to a 7.8-10.0 mmol/L target. (ClinicalTrials.gov # NCT00107601, EUDRA-CT Number: 200400391440).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A retrospective study suggested that tidal volumes should be lowered even with plateau pressures ≤ 30 cm H 2 O (431) because lower plateau pressures were associated with reduced hospital mortality (432).”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [431]
In the citing paper
“In the surgical ICU, earlier studies have indicated that intensive glucose control (80 to 110 mg/dL) inconsistently resulted in decreased length of stay.94–96”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [94]
In the citing paper
“Intensive glycemic control post-operatively, compared to less intensive targets, has resulted in equivocal or mixed results; however, other studies have shown no benefits.94,100,101,104”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [94]
In the citing paper
“Obese patients are only slightly more prevalent in the ICU than in the hospital and in the related populations.”
From ESPEN guideline on clinical nutrition in the intensive care unit. (2019) · cites this paper as [351]
In the citing paper
“There is a large variability in the prevalence between countries with more than 39% and 37% obese (BMI>30 kg/m 2 ) present in the US ICUs and hospital wards, 22% and 19% in Europe, 17% and 14% in South America and 10% and 7% in the Asian and Pacific region based on data from the Nutrition Day project (6,351).”
From ESPEN guideline on clinical nutrition in the intensive care unit. (2019) · cites this paper as [351]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
APACHE II: A severity of disease classification system
KNAUS, W. A., DRAPER, E. A., WAGNER, D. P., & ZIMMERMAN, J. E. (1985) · Critical Care Medicine · doi:10.1097/00003246-198510000-00009 · Cited by 13,664
APACHE II-A Severity of Disease Classification System: Reply
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1986) · Critical Care Medicine · doi:10.1097/00003246-198608000-00028 · Cited by 13,376 · cited 1×
“The Acute Physiological and Chronic Health Evaluation (APACHE II) on admission [11] and the daily Sequential Organ Failure Assessment (SOFA) [12] scores and the presence of diabetes were recorded.”
MethodVincent, J. L., Moreno, R., Takala, J., Willatts, S., De Mendonça, A., Bruining, H., Reinhart, C. K., Suter, P. M., & Thijs, L. G. (1996) · Intensive Care Medicine · doi:10.1007/bf01709751 · Cited by 11,674 · cited 9×
“The overall severity of organ failures assessed by daily SOFA scores were similar in both groups as were the other severity indices of illness, the number of febrile days and the number of days with anti-infective agents, except for the number of patient days with vasopressors/inotropes which was higher in the group 2…”
MethodInfluentialIntensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
Intensive versus Conventional Glucose Control in Critically Ill Patients
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810625 · Cited by 5,119 · cited 1×
“Nevertheless, the mortality was slightly and not significantly increased in the group 2, consistently with other recent prospective trials [7, 14, 18, 19].”
ResultIntensive insulin therapy in the medical ICU
Van den Berghe, G., Wilmer, A., Hermans, G., Meersseman, W., Wouters, P. J., Milants, I., Van Wijngaerden, E., Bobbaers, H., & Bouillon, R. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052521 · Cited by 3,639 · cited 9×
“The proportion of time in range calculated from morning BG values was not lower than in the most of the other studies [6, 7, 13, 17].”
BackgroundMethodResultInfluentialIntensive insulin therapy and pentastarch resuscitation in severe sepsis
Brunkhorst, F. M., Engel, C., Bloos, F., Meier-Hellmann, A., Ragaller, M., Weiler, N., Moerer, O., Gruendling, M., Oppert, M., Grond, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa070716 · Cited by 2,921
Riker, R. R. (2009) · JAMA · doi:10.1001/jama.2009.56 · Cited by 1,672
Dungan, K. M., Braithwaite, S. S., & Preiser, J.-C. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60553-5 · Cited by 1,431
Self-citationKrinsley, J. S. (2003) · Mayo Clinic Proceedings · doi:10.4065/78.12.1471 · Cited by 1,165 · cited 1×
“with other recent findings [14, 25].”
Research works printed but not linked: 2
- Devos P, Preiser JC, Melot C (2007) Impact of tight glucose control by intensive insulin therapy on ICU mortality and the rate of hypoglycaemia: final results of the Glucontrol study. Intensive Care Med 33:S189
- Devos P, Ledoux D, Preiser JC (2005) Current practice of glycaemia control in European intensive care units (ICUS). Intensive Care Med 31:S203
Cited by
Items 601–700 of 912
Breeding, J., Welch, S. A., Buscher, H., Nair, P., Frost, C., Newman, S., & Whittam, S. (2014) · Australian Critical Care · doi:10.1016/j.aucc.2014.07.002 · Cited by 4
Weiß, M., Kron, M., Hay, B., Taenzer, M., Radermacher, P., & Georgieff, M. (2011) · Patient Safety in Surgery · doi:10.1186/1754-9493-5-5 · Cited by 4
“7% [33] and 16% [10] in the IIT group, respectively, in mixed surgical/medical ICUs.”
BackgroundGeneralizability of a Nonlinear Model-based Glycemic Controller
Stewart, K. W., Pretty, C. G., Thomas, F., Shaw, G. M., Desaive, T., Benyó, B. I., Homlok, J., Illyés, A., Némedi, N. S., & Chase, J. G. (2016) · IFAC-PapersOnLine · doi:10.1016/j.ifacol.2016.07.115 · Cited by 4
Methodology for the analysis and comparison of protocols for glycaemic control in intensive care
Fernández‐Méndez, R., Rodríguez-Villar, S., Méndez, P. F., Windle, R. J., & Adams, G. G. (2018) · Journal of Evaluation in Clinical Practice · doi:10.1111/jep.13047 · Cited by 4
Accuracy and Stability of a Subcutaneous Flash Glucose Monitoring System in Critically Ill Patients
Naraba, H., Goto, T., Tokuda, M., Sonoo, T., Nakano, H., Takahashi, Y., Hashimoto, H., & Nakamura, K. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/19322968211017203 · Cited by 5
“8) 1,332 (66) 666 (33) MARD 20 [11, 67] 15 [11, 67] 10 [4, 18] CEG zone A 9 (56) 784 (59) 503 (75) B 5 (31) 540 (41) 160 (24) C 2 (13) 8 (1) 3 (0) D 0 (0) 0 (0) 0 (0) E 0 (0) 0 (0) 0 (0)”
BackgroundWhyte, M., Vas, P. R. J., & Umpleby, A. M. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.649405 · Cited by 4
Corneille, M. G., Villa, C., Wolf, S. E., Michalek, J. E., Jung, I., Wade, C. E., Myers, J. G., Dent, D. L., Mueller, D. L., & Stewart, R. M. (2010) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2010.07.034 · Cited by 4
“8%, is consistent with these other studies.(37,38) Although 16% may seem comparatively high at first glance, these values are not indexed by number of patient days or presented as a proportion of total glucose values obtained.”
ResultInfluence of smart real-time electronic alerting on glucose control in critically ill patients
Colpaert, K. E., Oeyen, S. G., Sijnave, B., Peleman, R. A., Benoît, D., & Decruyenaere, J. M. A. (2014) · Journal of Critical Care · doi:10.1016/j.jcrc.2014.07.030 · Cited by 4
Glycaemic control in intensive care: Everything in moderation
Devanesan, A., Lloyd, J., Samad, H., & Saha, S. (2016) · Journal of the Intensive Care Society · doi:10.1177/1751143716644455 · Cited by 5
“showed no mortality benefit to intensive glycaemic control and an increased risk of hypoglycaemia.(9,10) As such, most international guidelines have increased their target for glycaemic control since 2009 to reflect this.”
BackgroundChallenging orthodoxy in critical care trial design: physiological responsiveness
Aberegg, S. K. (2016) · Annals of Translational Medicine · doi:10.21037/atm.2016.03.45 · Cited by 4
“The first problem is that of “positive” trials that cannot be replicated (2-15).”
BackgroundHigh Glucose Variability in Hospitalized Patients with Type 1 Diabetes Mellitus
Dadlani, V., Tamhane, S. U., Sun, A.-D., Sharma, A. R., Delivanis, D. A., Thapa, P. B., Carter, R. E., & Kudva, Y. C. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0107 · Cited by 4
“Targeted Blood Glucose and Their Outcomes in Various Studies Studies Study design/ no. patients/ clinical setting Targeted BG Outcomes Intensive BG controla Conventional BGa Hypoglycemic episodes Mortality rate Van den Berghe et al.8 Single center prospective RCT 4.4–6.1 10–12 5% intensive control 4.6% intensive contr…”
BackgroundInfluentialMontanier, N., Bernard, L., Lambert, C., Pereira, B., Desbiez, F., Terral, D., Abergel, A., Bohatier, J., Rosset, E., Schmidt, J., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0211425 · Cited by 4
Preiser, J., Thooft, A., & Tironi, R. M. (2016) · Springer eBooks · doi:10.1007/978-3-319-27687-8_8 · Cited by 4
Self-citationThe enigma of glucose and cardiovascular disease
Desouza, C. V., Raghavan, V. A., & Fonseca, V. A. (2010) · Heart · doi:10.1136/hrt.2009.191866 · Cited by 5
“The latter two studies had to be stopped prematurely as a result of excess hypoglycaemia.(25) 26 A study by Kosiborod et al,(27) looking at 16 871 patients admitted with myocardial infarction found that a J-shaped relationship existed between glucose and mortality.”
BackgroundContinuous Glucose Monitoring and Tight Glycaemic Control in Critically Ill Patients
Signal, M. (2013) · UC Research Repository (University of Canterbury) · doi:10.26021/3559 · Cited by 6
Seret, M., Uyttendaele, V., Chase, J. G., Shaw, G. M., & Desaive, T. (2026) · Journal of Diabetes Science and Technology · doi:10.1177/19322968251412857 · Cited by 3
Sirimaturos, M., Honarmand, K., Long, M. T., Preiser, J., Nagpal, D., Agus, M. S. D., Aldouhan, J., Bircher, N. G., Carpenter, D. L., Dearness, K. L., et al. (2026) · Critical Care Medicine · doi:10.1097/ccm.0000000000007175 · Cited by 3
Self-citationEvaluation and Enhancement of an Intraoperative Insulin Infusion Protocol via In-Silico Simulation
Kohl, B., Chen, S., Mullen‐Fortino, M., & Lee, I. (2013) · IEEE International Conference on Healthcare Informatics (ICHI) · doi:10.1109/ichi.2013.43 · Cited by 5
“Subsequent enthusiasm for aggressive glucose management, however, has tempered as multiple groups attempting to replicate those results were unable to show comparable reductions in morbidity and mortality and have consistently observed high rates of hypoglycemia [20], [21], [22], [23], [24], [25].”
Genay, S., Décaudin, B., Ethgen, S., Alluin, A., Babol, E., Labreuche, J., Behal, H., Vantyghem, M., Odou, P., & Lebuffe, G. (2017) · Annals of Intensive Care · doi:10.1186/s13613-017-0298-x · Cited by 3
“Patients require continuous intravenous insulin infusion to control glucose level, but intensive insulin therapy (IIT) is often associated with an increased risk of hypoglycaemia [3, 4].”
BackgroundUse of Insulin in the Inpatient Setting: Need for Continued Use
Kumar, S., & Molitch, M. E. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1183-9 · Cited by 3
Tanioka, N., Maeda, H., Uemura, S., Munekage, M., Kitagawa, H., Namikawa, T., Kuroiwa, H., Fujimoto, S., Seo, S., & Hanazaki, K. (2023) · Artificial Organs · doi:10.1111/aor.14547 · Cited by 4
Doola, R., Dupuis, C., & Preiser, J. (2024) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000001039 · Cited by 3
“Given carbohydrates are an integral energy source in the human diet [22], the majority of energy provision within this formula tend to come from its carbohydrate content with most standard formula comprising carbohydrates that provide more than 40% of the total energy as compared to 29–35% formula…”
BackgroundSelf-citationModel-Based Medical Decision Support – A Road to Improved Diagnosis and Treatment?
Andreassen, S., Karbing, D. S., Pielmeier, U., Rees, S. E., Falborg, A. Z., Sanden, L. R., Paul, M., & Leibovici, L. (2011) · World Congress on Medical Physics and Biomedical Engineering, September 7 - 12, 2009, Munich, Germany · doi:10.1007/978-3-642-21683-1_65 · Cited by 3
“The paper will also review progress achieved using a model-based approach combined with decision theory to construct MDS systems in several important clinical areas, including control of hyperglycaemia by insulin administration to patients in the intensive care unit (ICU) (Glucosafe) [3-12], optimization of mechanical…”
BackgroundMethodPhysiopathologie de la dénutrition en réanimation
Hssain, A. A., Souweine, B., & Cano, N. (2011) · Nutrition Clinique et Métabolisme · doi:10.1016/j.nupar.2011.01.001 · Cited by 3
Roh, G. U., Shim, J., Song, J. W., Kang, H. M., & Kwak, Y. L. (2015) · European Journal of Anaesthesiology · doi:10.1097/eja.0000000000000250 · Cited by 3
Admission hyperglycemia in sepsis is associated with poor outcomes: where do we go from here?
Szumita, P. M., & Gilmore, J. F. (2016) · Journal of Thoracic Disease · doi:10.21037/jtd.2016.05.17 · Cited by 3
“Mortality was substantially decreased in the intensive BG control arm in 1 randomized trial of surgical ICU patients, increased in the NICESUGAR trial of mixed ICU patients, and resulted in no difference in 3 others (5,10-13).”
BackgroundNeuroprotektion in der Neurointensivmedizin
Kollmar, R. (2019) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-019-00608-8 · Cited by 3
Reenberg, A. T., Boiroux, D., Ritschel, T. K. S., & Jørgensen, J. B. (2019) · IEEE Conference on Decision and Control (CDC) · doi:10.1109/cdc40024.2019.9029651 · Cited by 3
“However, in clinical studies, using a control algorithm administering insulin alone led to recurrent hypoglycemia [17], [18], unless the glucose target is set to a value outside the fasting normal range [19].”
BackgroundHyperglycemia associated with parenteral nutrition in noncritical patients
Pérez‐Cruz, E., Ramón, P., & Alberto, M.-M. F. (2020) · Human Nutrition & Metabolism · doi:10.1016/j.hnm.2020.200114 · Cited by 4
In‐Hospital Treatment and Surgery in People with Diabetes
Dhatariya, K., Newland‐Jones, P., & Patel, M. A. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch39 · Cited by 3
Szabó, B., Pintér, P., Antal, Á., Szlávecz, Á., Chase, J. G., & Benyó, B. I. (2024) · IFAC-PapersOnLine · doi:10.1016/j.ifacol.2024.11.058 · Cited by 3
Ručka, Z., Koutná, I., Tesařová, L., Potěšilová, M., Stejskal, S., Šimara, P., Vaňhara, P., Doležel, J., Zvoníček, V., Coufal, O., et al. (2014) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-14-155 · Cited by 3
“1 mmol/l decreases the number of hypoglycemic patients while preserving the beneficial effects of insulin therapy [13,14].”
BackgroundLink, P., Ee, M., Jones, T. N., & Fa, M. (2009) · Cited by 3
Effectiveness of Tight Glycemic Control in the Medical Intensive Care Unit: A Systematic Review
Merrill, A., & Jones, S. (2010) · JBI Library of Systematic Reviews · doi:10.11124/01938924-201008341-00001 · Cited by 3
Singer, P., & Cohen, J. D. (2010) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607110362769 · Cited by 3
Self-citationCarbohydrate Provision in the Era of Tight Glucose Control
Miller, K. R., Lawson, C. M., Smith, V. L., & Harbrecht, B. G. (2011) · Current Gastroenterology Reports · doi:10.1007/s11894-011-0204-x · Cited by 3
Radbel, J. M., & Boutsikaris, D. G. (2016) · Emergency Medicine Clinics of North America · doi:10.1016/j.emc.2016.08.007 · Cited by 3
Nutrition Support and Tight Glucose Control in Critically Ill Children: Food for Thought!
Srinivasan, V. (2018) · Frontiers in Pediatrics · doi:10.3389/fped.2018.00340 · Cited by 4
Laichuthai, N., Khovidhunkit, W., & Boonchaya‐anant, P. (2019) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-019-00731-4 · Cited by 3
Glucose Control in the Intensive Care Unit
Gunst, J., & den Berghe, G. V. (2020) · Springer eBooks · doi:10.1007/978-3-030-53370-0_42 · Cited by 3
Glucose intolerance in intensive care patients: Incidence and outcome
Shebiny, A. A. E., Elewa, G. M., Gouda, E. A. G., & Hashim, R. M. (2020) · Egyptian Journal of Anaesthesia · doi:10.1080/11101849.2020.1864253 · Cited by 3
“Moreover, mortality risk increased with tight glycemic control [17,18].”
BackgroundTranslating A Risk-Based Glycaemic Control Framework for Critically Ill Patients: STAR-Liège
Uyttendaele, V., Knopp, J. L., Pirotte, M., Morimont, P., Lambermont, B. C., Shaw, G. M., Desaive, T., & Chase, J. G. (2020) · Open Repository and Bibliography (University of Liège) · Cited by 3
Effectiveness of tight glycemic control in the medical Intensive Care Unit: a systematic review
Merrill, A., & Jones, S. (2011) · JBI Library of Systematic Reviews · doi:10.11124/jbisrir-2011-122 · Cited by 3
Management of Patients with Diabetes in the Intensive Care Unit
Cieślak, J., Levin, A., & Beaulieu, M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-44942-7.00215-6 · Cited by 4
Glycemic Control during Critical Illness: Tight or Not?
Dickerson, R. N. (2009) · Hospital Pharmacy · doi:10.1310/hpj4412-1142 · Cited by 3
“center, multinational trial in medical and surgical ICU patients to evaluate the efficacy of an intensive insulin infusion (80 to 110 mg/dL) versus moderate therapy (140 to 180 mg/dL).(6) The intensive insulin therapy resulted in early discontinuation of the study due to a high rate of unintended protocol violations a…”
BackgroundLal, A., Haque, N., Lee, J., Katta, S. R., Maranda, L., George, S. V., & Trivedi, N. (2021) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · doi:10.23750/abm.v92i1.9083 · Cited by 3
“the measurement, followed by intervention (23).”
In-silico assessment of longer measurement intervals in glycaemic control to match clinical practice
Seret, M., Uyttendaele, V., Chase, J. G., & Desaive, T. (2025) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2025.108806 · Cited by 2
Alkhafaf, O. S., Chase, J. G., & Benyó, B. I. (2025) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2025.105964 · Cited by 2
Xia, Z., Meng, J., Mei, L., Peng, H., Dai, X., He, B., Liu, P., Wu, Y., & Gao, S. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.113034 · Cited by 2
Struja, T., Hansen, L., de Matos, J. C. R. G., Gómez, J., Pardo, A., Lourentzou, I., Hejazi, N. S., Celi, L. A., & Waschka, A. K. (2026) · BMJ Open · doi:10.1136/bmjopen-2025-104916 · Cited by 2
Diabetes Management Strategies in Intensive Care Settings
Gunst, J., Galindo, R. J., Umpierrez, G. E., & den Berghe, G. V. (2026) · Medical Clinics of North America · doi:10.1016/j.mcna.2026.01.015 · Cited by 3
Watkinson, P., Barber, V. S., & Young, D. (2018) · JMIR Research Protocols · doi:10.2196/resprot.5912 · Cited by 3
“2 mmol/L (this low level is set to be in agreement with other completed and in-progress trials [5,34-38]).”
ResultBlood Glucose Control in Critical Care
Mårtensson, J., Egi, M., & Bellomo, R. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-44942-7.00079-0 · Cited by 3
Closed-loop management of inpatient hyperglycaemia
Boughton, C. K., & Hovorka, R. (2019) · British Journal of Hospital Medicine · doi:10.12968/hmed.2019.80.11.665 · Cited by 2
A stochastic model-based control methodology for glycemic management in the intensive care unit
Sirlanci, M., Hripcsak, G. M., Wang, C. C. L., Stroh, J. N., Wang, Y., Bennett, T. D., Stuart, A. M., & Albers, D. J. (2024) · Frontiers in Medical Engineering · doi:10.3389/fmede.2024.1419786 · Cited by 2
“Even though these results changed how GM performed in the ICU, these results could not be replicated by follow-up clinical trials [4]–[11].”
Rangel, É. B. (2024) · Brazilian Journal of Nephrology · doi:10.1590/2175-8239-jbn-2024-0074pt · Cited by 2
Patek, S. D., Ortiz, E. A., Farhy, L. S., Mason, J. E., Isbell, J. M., Kirby, J. L., & McCall, A. L. (2015) · Proceedings of the ... American Control Conference/Proceedings of the American Control Conference · doi:10.1109/acc.2015.7172132 · Cited by 2
“computer-assisted) is expensive, time consuming, and potentially dangerous [21], [22], [23], [24], [25], and further large”
Continuous prediction of glucose-level changes using an electronic nose in critically ill patients
Leopold, J. H., van Hooijdonk, R. T. M., Bos, L. D. J., Winters, T., Sterk, P. J., Abu–Hanna, A., & Schultz, M. J. (2014) · Critical Care · doi:10.1186/cc13627 · Cited by 2
Intensive insulin management of inpatient hyperglycemia: Where are we?
Molitch, M. E. (2010) · Journal of Hospital Medicine · doi:10.1002/jhm.842 · Cited by 2
Talley, M. H., Hill, A. N., Steadman, L. A., & Hess, M. A. (2012) · Journal of the American Academy of Nurse Practitioners · doi:10.1111/j.1745-7599.2012.00770.x · Cited by 2
“Other studies have shown equitable safety concerns associated with intensive control, such as the Glucontrol Trial, or no overall benefit in this type of regimen (Preiser et al., 2009).”
BackgroundPlatikanov, V., Slavova, N., & Todorova, M. (2013) · Scripta Scientifica Medica · doi:10.14748/ssm.v45i1.329 · Cited by 2
Adjuvante Therapie der Sepsis: Was ist gesichert?
Wiedermann, C. J. (2014) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-014-0379-7 · Cited by 2
Chase, J. G., Compte, A. J. L., Preiser, J., Pretty, C. G., Moorhead, K. T., Penning, S., Shaw, G. M., & Desaive, T. (2011) · IFAC Proceedings Volumes · doi:10.3182/20110828-6-it-1002.01281 · Cited by 2
“However, safely achieving improved outcomes with TGC has been difficult (Finfer et al., 2009, Preiser et al., 2009) due largely to significant increases in hypoglycemia and glycemic variability in TGC cohorts.”
BackgroundSelf-citationGlycemic control during critical illness
Preiser, J. (2011) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.11.58 · Cited by 2
Self-citationKidney Injury, Insulin Therapy, and Hypoglycemia
Dickerson, R. N. (2012) · Journal of Pharmacy and Nutrition Sciences · doi:10.6000/1927-5951.2012.02.01.6 · Cited by 2
“Such is the case with the Glucontrol trial whereby frequent protocol violations by nursing personnel and a high rate of severe hypoglycemia led to its premature discontinuation [34].”
BackgroundLa variabilité glycémique en réanimation
Schaal, J. V., Libert, N., de Rudnicki, S., Auroy, Y., & Merat, S. (2012) · Annales Françaises d Anesthésie et de Réanimation · doi:10.1016/j.annfar.2012.09.002 · Cited by 2
Réanimation métabolique du myocarde : à la redécouverte de l’insuline
Massion, P. B., & Preiser, J. (2010) · Réanimation · doi:10.1016/j.reaurg.2010.05.018 · Cited by 2
Self-citationPerioperative Glucose Management
Wei, N., & Wexler, D. J. (2012) · Hospital Medicine Clinics · doi:10.1016/j.ehmc.2012.05.002 · Cited by 2
“9 mmol/L]) (17-19); moreover, it was difficult to achieve without hypoglycemia.”
BackgroundThe Resuscitation Package in Sepsis
Demertzis, L. M., & Kollef, M. H. (2010) · Current Infectious Disease Reports · doi:10.1007/s11908-010-0121-4 · Cited by 2
“Preiser et al. [ 40 ], Finfer et al. [41] Maintenance of blood glucose <150-200 mg/dL using a validated intravenous insulin protocol”
MethodChelazzi, C., Ricci, Z., & Romagnoli, S. (2015) · Springer eBooks · doi:10.1007/978-3-319-17515-7_8 · Cited by 2
“The study was interrupted for protocol violations, and although IIT was associated with increased risk of hypoglycemia and a trend toward increased mortality, blood glucose levels were poorly controlled [ 21 ].”
BackgroundImpact of a Quality Improvement Project on Deceased Organ Donor Management
Olmos, A., Feiner, J., Hirose, R., Swain, S., Blasi, A., Roberts, J. P., & Niemann, C. U. (2015) · Progress in Transplantation · doi:10.7182/pit2015129 · Cited by 2
“Although the mortality benefit of tight glucose control in the intensive care unit is debated, studies in the critical care setting have demonstrated that tight glucose control is renoprotective in critically ill patients.(20-32) Despite this evidence, hyperglycemia in deceased organ donors has been largely ignored un…”
BackgroundEffect of blood-sugar limitation on intensive care mortality: Intragroup evaluation
Nachtigall, I., Tafelski, S., Tamarkin, A., Rothbart, A., Lange, M., Wegener, F., Balzer, F., Burgos, J. P. L., Wernecke, K., & Spies, C. (2015) · Journal of International Medical Research · doi:10.1177/0300060514566651 · Cited by 2
“However, when defined as a moderate group, there was no statistically significant difference between the two subgroups (3 [2–9] days for the euglycaemic subpopulation versus 4 [2–9] days for the dysglycaemic subpopulation, P1⁄4 0.”
BackgroundSchiller, F. (2013) · Cited by 4
Hyperglycemia in Critical Illness
Weant, K. A., Bailey, A. M., & Baker, S. N. (2013) · Advanced Emergency Nursing Journal · doi:10.1097/tme.0b013e31829e5b96 · Cited by 4
“…initial fervor surrounding intensive insulin therapy, several additional trials were conducted and did not replicate the findings of the initial 2001 study (Arabi et al., 2008; Brunkhorst et al., 2008; De La Rosa Gdel et al., 2008; Finfer et al., 2009; Marik & Preiser, 2010; Preiser et al., 2009).”
BackgroundResultTrends in practice of blood glucose control in critically ill patients in the Netherlands.
van Hooijdonk, R. T. M., Eslami, S., de Keizer, N. F., Bakhshi‐Raiez, F., Rj, B., Dongelmans, D. A., van der Voort, Streefkerk, J. O., Wj, E., ten Cate, J., et al. (2015) · PubMed · Cited by 3
Diseases of the Endocrine System
Akhtar, S. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-2787-6.00013-9 · Cited by 3
Acute severe illness in diabetes patients: is tolerating hyperglycemia beneficial?
Gunst, J., & den Berghe, G. V. (2016) · Journal of Thoracic Disease · doi:10.21037/jtd.2016.11.55 · Cited by 3
Glukosemanagement in der Intensivmedizin
Lindner, M., & Elke, G. (2017) · Aktuelle Ernährungsmedizin · doi:10.1055/s-0043-108683 · Cited by 2
“Auch die a priori definierten Endpunkte waren in den FALLBEISPIEL 4 Ernährungsmedizinische Therapie – praktisches Vorgehen ▪ Bestimmung von Blutglukose und Serumelek- trolytwerten (Natrium, Kalium) in einer arteriellen Blutgasanalyse sowie von Phosphat, Magnesium, Triglyzeriden und Harnstoff im Zentrallabor ▪ Blutgluk…”
BackgroundInfluentialDickson, J. L., & Chase, J. G. (2019) · IFAC-PapersOnLine · doi:10.1016/j.ifacol.2019.01.021 · Cited by 2
STAR-3D Clinical Trial Results: Improved performance and safety
Uyttendaele, V., Knopp, J. L., Desaive, T., & Chase, J. G. (2021) · IFAC-PapersOnLine · doi:10.1016/j.ifacol.2021.10.304 · Cited by 2
Taylor, N. F., Puch, I. C., Silvestri, L., Zandstra, D. F., & SAENE, H. K. F. V. (2011) · Springer eBooks · doi:10.1007/978-88-470-1601-9_28 · Cited by 2
The Endocrine Response to Critical Illness
Peeler, K. R., & Agus, M. S. D. (2018) · Springer eBooks · doi:10.1007/978-3-319-73782-9_38 · Cited by 2
Should Blood Glucose Be Tightly Controlled in the Intensive Care Unit?
Preiser, J. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5476-4.00072-9 · Cited by 2
Self-citationIba, T., Mayumi, T., Ogura, S., Ishikura, H., Kotani, J., Matsuda, N., & Yokota, H. (2009) · Nihon Kyukyu Igakukai Zasshi Journal of Japanese Association for Acute Medicine · doi:10.3893/jjaam.20.915 · Cited by 2
Razak, A. R. B. A. (2012) · UC Research Repository (University of Canterbury) · doi:10.26021/2810 · Cited by 3
Evidence lost to treatment of critically-ill patients?
Schultz, M. J., Spronk, P. E., Afessa, B., & Gajic, O. (2009) · PubMed · Cited by 3
Disease or adaptation: another look at the practice of medicine
Soeters, P. B., & de Leeuw, P. W. (2018) · Postgraduate Medicine · doi:10.1080/00325481.2018.1433435 · Cited by 1
“tality), when tight sugar control was combined with limitation of carbohydrate ingestion [9,10], compared with a more liberal approach aiming for modest hyperglycemia and liberal 240 P.”
Duhailib, Z. A., Hakeam, H. A., Almossalem, A., Alrashidi, A., Zhrani, A. A. A., Salman, H. A., Alenizy, K., Alqafashat, S., Alshalawi, M., Mohamed, G., et al. (2024) · Endocrine Practice · doi:10.1016/j.eprac.2024.12.014 · Cited by 1
de Watteville, A., Pielmeier, U., Marco, M. D., Gayet‐Ageron, A., Siegenthaler, N., Parel, N., Wozniak, H., Primmaz, S., Pugin, J., Andreassen, S., et al. (2025) · PLoS ONE · doi:10.1371/journal.pone.0316624 · Cited by 1
Sepsis as CNS-governed metabolic triage
Yurtsever, B., & Demirkol, D. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1842915 · Cited by 1
Idrees, T., Nalabolu, S., Oladejo, O., Elshimy, G., Orobio, C., & Umpierrez, G. E. (2026) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2026-006533 · Cited by 1
Hyperglycemia should be Avoided in Critical Illness and the Postoperative Period
Muthusamy, K., & Miles, J. M. (2011) · Wiley eBooks · doi:10.1002/9781444340280.ch15 · Cited by 1
Schwartz, S. S., & DeFronzo, R. A. (2014) · Diabetes Care · doi:10.2337/dc13-1783 · Cited by 1
Diagnose und Therapie der Sepsis
Schürholz, T., & Marx, G. (2011) · Springer eBooks · doi:10.1007/978-3-642-16929-8_63 · Cited by 1
Diabetes in the Pediatric Surgical Patient
Wassner, A. J., & Agus, M. S. D. (2017) · Springer eBooks · doi:10.1007/978-3-662-54256-9_15 · Cited by 1
Translational Metabolomics of Head Injury
Wolahan, S. M., Hirt, D., & Glenn, T. C. (2015) · Cited by 1
Diabetes and the Cardiovascular System
Cohen, P., & Plutzky, J. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6705-2_41 · Cited by 1
Orban, J., Lena, D., Preiser, J., & Ichaï, C. (2011) · Springer eBooks · doi:10.1007/978-2-287-99027-4_19 · Cited by 1
Self-citationHospital Strategies for Insulin Therapy with Rapid-Acting Insulin Analogs
Campbell, R. K. (2011) · Hospital Pharmacy · doi:10.1310/hpj4608-580 · Cited by 1
A model-based clinically-relevant chemotherapy scheduling algorithm for anticancer agents
Ho, T. (2014) · D-Scholarship@Pitt (University of Pittsburgh) · Cited by 3
Metadata
- Authors
- Preiser, J.-C., Devos, P., Ruiz-Santana, S., Mélot, C., Annane, D., Groeneveld, J., Iapichino, G., Leverve, X., Nitenberg, G., Singer, P., Wernerman, J., Joannidis, M., Stecher, A., & Chioléro, R.
- Affiliations
- Centre Hospitalier Universitaire de Liège (BE)
- Erasmus Hospital (BE)
- Hôpital Raymond-Poincaré (FR)
- Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
- University of Milan (IT)
- Université Joseph Fourier (FR)
- Institut Gustave Roussy (FR)
- Rabin Medical Center (IL)
- Karolinska Institutet (SE)
- Universität Innsbruck (AT)
- Ljubljana University Medical Centre (SI)
- Centre Hospitalier Universitaire Vaudois (CH)
- Corresponding author
- Preiser, Jean-Charles
- ORCID
- Venue
- Intensive Care Medicine
- Published
- 2009-07-28
- Volume
- 35
- Issue
- 10
- Pages
- 1738-1748
- ISSN
- 0342-4642 (ISSN-L)
- 1432-1238
- OpenAlex
- W2139706988
- Cited by
- 911
- References
- 37
- Citations by year
- 2026: 16 · 2025: 15 · 2024: 24 · 2023: 33 · 2022: 23 · 2021: 32 · 2020: 31 · 2019: 48 · 2018: 48 · 2017: 46 · 2016: 57 · 2015: 69 · 2014: 80 · 2013: 76 · 2012: 95
- FWCI
- 75.27
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Intensive Care Medicine (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- HAL (submittedVersion)
- Acceda (Universidad de Las Palmas de Gran Canaria) (submittedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- Universidad de Las Palmas de Gran Canaria
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Intensive Care Unit Cognitive Disorders
- Keywords
- intensive insulin therapy, tight glycemic control, glycemic targets, critically ill adults, intensive care unit, ICU mortality, hypoglycemia, insulin therapy, early trial termination, protocol violations, time in target glucose range, ICU length of stay, cost-effectiveness, quality of life
- MeSH terms
- Aged, Blood Glucose, Female, Humans, Hyperglycemia, Hypoglycemic Agents, Insulin, Intensive Care Units, Male, Middle Aged, Prospective Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.